{"doc_id": "33492523", "type of study": "Therapy", "title": "", "abstract": "Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study.\nNo specific antiviral drugs have been approved for the treatment of COVID-19.\nThis study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19.\nThis was a multicenter randomized controlled study including 96 patients with COVID- 19 who were randomly assigned into a chloroquine (CQ) group and a favipiravir group.\nNone of the patients in the favipiravir group needed mechanical ventilation (p = 0.129).\nOne patient (2.3%) in the favipiravir group and two patients (4.2%) in the CQ group died (p = 1.00).\nFavipiravir is a promising drug for COVID-19 that decreases the hospital stay and the need for mechanical ventilation.\nClinicalTrials.gov Identifier NCT04351295.\n", "Evidence Map": {"Enrollment": [{"term": "COVID-19 treatment", "negation": "affirmed", "UMLS": {}, "start": 27, "end": 45}, {"term": "COVID-19", "negation": "affirmed", "UMLS": {}, "start": 73, "end": 81}, {"term": "COVID-19", "negation": "affirmed", "UMLS": {}, "start": 78, "end": 86}], "Comparison Results": [], "Study Arm 1 Results": [], "Study Arm 2 Results": [], "Hypothesis": []}, "Sentence-level breakdown": [{"Section": "TITLE", "Text": "Efficacy of favipiravir in COVID-19 treatment : a multi-center randomized study .", "Evidence Elements": {"Participant": [{"term": "COVID-19 treatment", "negation": "affirmed", "UMLS": {}, "start": 27, "end": 45}], "Intervention": [{"term": "favipiravir", "negation": "affirmed", "UMLS": {}, "start": 12, "end": 23}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "No specific antiviral drugs have been approved for the treatment of COVID-19 .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "This study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19 .", "Evidence Elements": {"Participant": [{"term": "COVID-19", "negation": "affirmed", "UMLS": {}, "start": 73, "end": 81}], "Intervention": [{"term": "favipiravir", "negation": "affirmed", "UMLS": {}, "start": 45, "end": 56}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "This was a multicenter randomized controlled study including 96 patients with COVID-19 who were randomly assigned into a chloroquine ( CQ ) group and a favipiravir group .", "Evidence Elements": {"Participant": [{"term": "COVID-19", "negation": "affirmed", "UMLS": {}, "start": 78, "end": 86}], "Intervention": [{"term": "chloroquine ( CQ )", "negation": "affirmed", "UMLS": {}, "start": 121, "end": 139}, {"term": "favipiravir", "negation": "affirmed", "UMLS": {}, "start": 152, "end": 163}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "None of the patients in the favipiravir group needed mechanical ventilation ( p = 0.129 ) .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "favipiravir", "negation": "negated", "UMLS": {}, "start": 28, "end": 39}], "Outcome": [{"term": "mechanical ventilation", "negation": "negated", "UMLS": {}, "start": 53, "end": 75}], "Observation": [], "Count": [{"term": "None of the patients", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 20}]}, "Evidence Propositions": [{"Intervention": "favipiravir", "Observation": "", "Count": "None of the patients", "Outcome": "mechanical ventilation"}]}, {"Section": "UNKNOWN", "Text": "One patient ( 2.3 % ) in the favipiravir group and two patients ( 4.2 % ) in the CQ group died ( p = 1.00 ) .", "Evidence Elements": {"Participant": [], "Intervention": [{"term": "favipiravir", "negation": "affirmed", "UMLS": {}, "start": 29, "end": 40}], "Outcome": [], "Observation": [], "Count": [{"term": "One patient ( 2.3 % )", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 21}, {"term": "two patients ( 4.2 % )", "negation": "affirmed", "UMLS": {}, "start": 51, "end": 73}]}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Favipiravir is a promising drug for COVID-19 that decreases the hospital stay and the need for mechanical ventilation .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "ClinicalTrials.gov Identifier NCT04351295 .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}]}